return to news
  1. Amanta Healthcare share price: Stock lists at over 7% premium on NSE; here's how much investors gained per lot

Market News

Amanta Healthcare share price: Stock lists at over 7% premium on NSE; here's how much investors gained per lot

Kamal Joshi

2 min read | Updated on September 09, 2025, 10:08 IST

Twitter Page
Linkedin Page
Whatsapp Page

SUMMARY

Amanta Healthcare share price: The ₹126 crore initial public offering is purely a fresh issuance of 1 crore equity shares with no offer for sale (OFS) component. It had a price range of ₹120 to ₹126 per share.

Amanta Healthcare makes sterile liquid products. | Image: amanta.co.in

Amanta Healthcare makes sterile liquid products. | Image: amanta.co.in

Amanta Healthcare share price: Shares of pharmaceutical player Amanta Healthcare debuted at ₹135 apiece on the National Stock Exchange (NSE) on Tuesday, September 9. This reflects a premium of 7.14% over the IPO issue price of ₹126 per unit.

On the BSE (formerly Bombay Stock Exchange), it started trading at ₹134, up 6.35% from the issue price.

Amanta Healthcare share price: Here's how much investors gained per lot

A lot consisted of 119 equity shares. Retail investors who received Amanta Healthcare IPO allotment made ₹16,065 per lot.

The initial public offering secured bids for 57,82,80,738 shares as against 70,00,000 shares reserved, leading to an 82.61 times subscription, as per the NSE data.

The part set aside for non-institutional investors (NIIs) was booked 209.42 times, while the retail investors category was subscribed 54.98 times. The quota for qualified institutional buyers, or QIBs, was subscribed 35.86 times.

CategoryReservedNo of Shares Bid ForNo of Times
QIBs20,00,0007,17,22,49035.86
NIIS15,00,00031,41,35,486209.42
RIIs35,00,00019,24,22,76254.98
Total70,00,00057,82,80,73882.61

The ₹126 crore initial public offering is purely a fresh issuance of 1 crore equity shares with no offer for sale (OFS) component. It had a price range of ₹120 to ₹126 per share.

The objectives of the issue include funding capital expenditure for setting up a new manufacturing line of SteriPort, establishing a new manufacturing line for SVP, and corporate general purposes.

Pharmaceutical company Amanta Healthcare is into the making of sterile liquid products, mainly parenteral products. It also manufactures medical devices.

Prior to the IPO, Amanta Healthcare secured ₹37.80 crore from anchor investors, including Bandhan Small Cap Fund, Perpetuity Health to Wealth (H2W) Rising Fund, Sanshi Fund-1, Sunrise Investment Trust- Sunrise Investment Opportunities Fund, Aarth Growth Fund, and Finavenue Capital Trust- Finavenue Growth Fund.

Beeline Capital Advisors was the book running lead manager to the offering.

To learn more about IPOs, their listings, schedules, and upcoming IPOs, visit our page.
SIP
Consistency beats timing.
promotion image

About The Author

Kamal Joshi
Kamal Joshi is a business journalist who covers industries, markets, and IPOs. He is passionate about breaking news and enjoys playing tennis, especially flexing his backhand. He was previously associated with Republic TV and LatestLY.